Takeda Pharmaceutical
TAK
#489
Rank
HK$368.16 B
Marketcap
HK$110.63
Share price
0.28%
Change (1 day)
5.89%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$385.79 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are HK$385.79 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31HK$379.46 B-6.3%
2024-03-31HK$404.96 B-9.52%
2023-03-31HK$447.57 B-7.18%
2022-03-31HK$482.17 B-11.2%
2021-03-31HK$542.99 B-6.95%
2020-03-31HK$583.58 B-4.12%
2019-03-31HK$608.67 B294.66%
2018-03-31HK$154.22 B-7.91%
2017-03-31HK$167.47 B33.97%
2016-03-31HK$125.00 B-7.4%
2015-03-31HK$135.00 B-11.44%
2014-03-31HK$152.43 B8%
2013-03-31HK$141.14 B4.73%
2012-03-31HK$134.76 B122.3%
2011-03-31HK$60.62 B11.25%
2010-03-31HK$54.49 B-1.79%
2009-03-31HK$55.48 B38.46%
2008-03-31HK$40.06 B-1.22%
2007-03-31HK$40.56 B-11.61%
2006-03-31HK$45.89 B16.5%
2005-03-31HK$39.39 B-5.37%
2004-03-31HK$41.62 B27.87%
2003-03-31HK$32.55 B2.07%
2002-03-31HK$31.89 B4.07%
2001-03-31HK$30.64 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$883.35 B 128.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$513.70 B 33.16%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
HK$899.66 B 133.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$486.55 B 26.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
HK$8.43 B-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$15.75 B-95.92%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
HK$626.47 B 62.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$476.80 B 23.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$604.04 B 56.57%๐Ÿ‡บ๐Ÿ‡ธ USA